We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 501

Telemedicine and the Interstate Medical Licensure Compact is here: will it succeed?

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • September 25 2014

After more than 18 months in the works, and with much public coverage in the telemedicine industry, the Federation of State Medical Boards (FSMB

Telemedicine: what’s next 2014 provider survey

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • September 25 2014

Telemedicine is a booming sector for health care, stemming from a strong desire to improve the overall quality of care and reach new patients in new

FDA's proposed oversight of laboratory developed tests - industry impact

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • September 23 2014

The U.S. Food and Drug Administration (FDA) recently announced that the Agency is lifting its enforcement discretion over high-risk laboratory

Transitional compliance period for business associate agreements expiring September 23, 2014

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • September 19 2014

If they have not already done so, covered entities and business associates have until September 23, 2014, to update their business associate

Privacy issues in the sharing of genetic information

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • September 18 2014

Scientific breakthroughs and technological advancements have led to the emergence of personalized medicine a practice based on the use of an

Unlocking the Promise of Personalized Medicine: Reimbursement, Coverage, and Clinical Utility

  • Foley & Lardner LLP
  • -
  • European Union, USA
  • -
  • September 15 2014

AmerisourceBergen, in connection with the Business of Personalized Medicine Summit, released "Unlocking the Promise of Personalized Medicine:

Medicare bundled payments initiative and oncology care

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • September 9 2014

According to Modern Healthcare’s “Interest Surges in Medicare Bundled Payment Initiative” article on July 31, 2014, enthusiasm for bundled pricing

Federal Circuit frames test for patent-eligibility

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • September 8 2014

Personalized medicine relies on diagnostics to analyze a patient for individualized therapy and for monitoring a patient's health status. Some

CMS says: let's make a deal

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • September 4 2014

In the hours before everyone began enjoying Labor Day Weekend, the Centers for Medicare & Medicaid Services (CMS) issued an important inpatient

7th Circuit defines "worthless services" under the False Claims Act

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • September 4 2014

That’s the upshot from U.S. ex rel. Absher v. Momence Meadows Nursing Center, Nos. 13-1886 & 13-1936 (Aug. 20, 2014), a recent decision from the